Back to Board of Directors

Gaurav Shah

CEO, Rocket Pharmaceuticals

Gaurav is the cofounder of Rocket Pharma, serving as Chief Executive Officer and Corporate Board Member. Prior to this role, Gaurav was a Global Program Head in the Cell & Gene Therapies Unit at Novartis, where he had strategic oversight of 12 functions and helped spearhead pivotal trials with CART-19 for patients with leukemia and lymphoma. Earlier roles at Novartis included Global Clinical Program Head for CART-19 and Biosimilars, and lead physician for Afinitor in several global oncology submissions. Gaurav started his career in industry at ImClone/Eli Lilly as a Medical Director overseeing oncology trials focused on monoclonal antibodies.

Gaurav graduated from Harvard College (summa cum laude, Phi Beta Kappa) with a degree in Behavioral Neuroscience. He received his MD from Columbia (AOA) and completed his internal medicine residency at Brigham and Women’s Hospital as well as hematology/oncology fellowship training at Memorial-Sloan Kettering. After receiving board certification in medical oncology, he served as an Adjunct Assistant Professor of Oncology at Columbia.